ABVC BioPharma Achieved its First Operational Profit, with a 102% Improvement over the Third Quarter of Last Year.Incremental Payments Received ...
Market Valuation: The endoscope reprocessing market is estimated to have a value of approximately USD 1.4 billion in 2022, ...
Gross profit for the three months ended September 30, 2024 decreased by $287 thousand, or 2%, to $11.8 million, from $12.0 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback